A systematic review and metaanalysis of antirheumatic drugs and vaccine immunogenicity in rheumatoid arthritis

S Subesinghe, K Bechman, AI Rutherford… - The Journal of …, 2018 - jrheum.org
Objective. Vaccination is a key strategy to reduce infection risk in patients with rheumatoid
arthritis (RA) and is advocated in internationally recognized rheumatology society guidelines. …

Serious infection across biologic-treated patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis

AI Rutherford, S Subesinghe, KL Hyrich… - Annals of the rheumatic …, 2018 - ard.bmj.com
Objectives To compare the incidence of serious infection (SI) across biologic drugs used to
treat rheumatoid arthritis (RA) using data from the British Society for Rheumatology Biologics …

Opportunistic infections in rheumatoid arthritis patients exposed to biologic therapy: results from the British Society for Rheumatology Biologics Register for …

AI Rutherford, E Patarata, S Subesinghe… - …, 2018 - academic.oup.com
Objectives This analysis set out to estimate the risk of opportunistic infection (OI) among
patients with RA by biologic class. Methods The British Society for Rheumatology Biologics …

[HTML][HTML] The effect of subclinical ketosis on activity at estrus and reproductive performance in dairy cattle

AJ Rutherford, G Oikonomou, RF Smith - Journal of Dairy Science, 2016 - Elsevier
Our aims were to investigate the influence of subclinical ketosis (SCK) on physical activity at
estrus using a neck accelerometer device and on future reproductive performance. Two …

IL-6 inhibition in the treatment of COVID-19: a meta-analysis and meta-regression

…, D Nagra, S Norton, MD Russell, AI Rutherford… - Journal of Infection, 2021 - Elsevier
Objectives Multiple RCTs of interleukin-6 (IL-6) inhibitors in COVID-19 have been published,
with conflicting conclusions. We performed a meta-analysis to assess the impact of IL-6 …

JAK inhibitors and the risk of malignancy: a meta-analysis across disease indications

…, MA Adas, F Atzeni, KKH Ng, AI Rutherford… - Annals of the …, 2023 - ard.bmj.com
Objectives To estimate the association of Janus kinase inhibitors (JAKi) with the incidence
of malignancy, compared with placebo, tumour necrosis factor (TNF)-α inhibitors (TNFi) and …

[HTML][HTML] Management of gout following 2016/2017 European (EULAR) and British (BSR) guidelines: an interrupted time-series analysis in the United Kingdom

MD Russell, AI Rutherford, B Ellis, S Norton… - The Lancet Regional …, 2022 - thelancet.com
Background Following studies reporting sub-optimal gout management, European (EULAR)
and British (BSR) guidelines were updated to encourage the prescription of urate-lowering …

[HTML][HTML] A large two-centre study in to rates of influenza and pneumococcal vaccination and infection burden in rheumatoid arthritis in the UK

S Subesinghe, AI Rutherford, F Ibrahim… - BMC musculoskeletal …, 2016 - Springer
Background Infections are a common complication of RA with associated morbidity and
mortality. The aetiology of increased risk is complex and multifactorial. Despite this, strategies to …

A population study of the reported incidence of native joint septic arthritis in the United Kingdom between 1998 and 2013

AI Rutherford, S Subesinghe, T Bharucha… - …, 2016 - academic.oup.com
Andrew Rutherford is funded by a clinical fellowship from the National Institute for Health
Research Biomedical Research Centre at Guy’s and St Thomas’ NHS Foundation Trust and …

Polypharmacy is associated with treatment response and serious adverse events: results from the British Society for Rheumatology Biologics Register for Rheumatoid …

K Bechman, BD Clarke, AI Rutherford, M Yates… - …, 2019 - academic.oup.com
Objective To evaluate whether polypharmacy is associated with treatment response and
serious adverse events (SAEs) in patients with RA using data from the British Society for …